Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abilia is a privately held Nordic assistive technology and healthcare device company focused on products that help people with disabilities and special needs live more independently. The company develops, manufactures, and sells solutions spanning cognitive support, communication aids, environmental control, alarms, seizure detection, and virtual care delivery. Abilia operates as part of MedCap’s Assistive Tech business area and has expanded through multiple add-on acquisitions, including Cognita, Alert-it, and LivAssured. Its products are marketed primarily in the Nordic region and the UK, with broader international distribution through resellers. Abilia is not a drug-development biotech company; it is a commercial-stage healthcare technology business centered on evidence-based assistive devices and care-enabling solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abilia.